European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.


BACKGROUND
The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2008. This manuscript updates these in a European setting.


METHODS
Systematic literature reviews.


RESULTS
The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk, general and pharmacological management of osteoporosis, monitoring of treatment, assessment of fracture risk, case finding strategies, investigation of patients and health economics of treatment.


CONCLUSIONS
A platform is provided on which specific guidelines can be developed for national use.
WHO Collaborating Centre, UK University of Sheffield Medical School, Sheffield, UK. w.j.pontefract@sheffield.ac.uk
J A
JA
Kanis
E V
EV
McCloskey
H
H
Johansson
C
C
Cooper
R
R
Rizzoli
J-Y
JY
Reginster
D015502:Absorptiometry, Photon; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000502:physiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods; D005060:Europe / Q000453:epidemiology; D005260:Female; D006620:Hip Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D055118:Medication Adherence; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D058866:Osteoporotic Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D018570:Risk Assessment / Q000379:methods
D015415:Biomarkers; D050071:Bone Density Conservation Agents